Buy Stocks Easy | About Us
January 17, 2022
Buy Stocks Easy | Online Stocks

ALKS


Buy Alkermes plc Stock (symbol: ALKS) Easy Online

Company Name: Alkermes plc

Symbol: ALKS

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2000

ALKS Current Share Price

Today's ALKS ( Alkermes plc ) opening price: $21.2500

Yesterday's ALKS ( Alkermes plc ) closing price: $21.0600

Alkermes plc Stock ( symbol: ALKS ) Price Chart since IPO (2000):

12 Months Alkermes plc Stock ( symbol: ALKS ) Price Chart

Popular Questions about Alkermes plc Public Stock ( ALKS )

A: Alkermes plc stock symbol (also called stock or share ticker) is ALKS

A: Alkermes plc IPO (Initial Public Offering) took place on 2000

A: Alkermes plc's stock (ALKS symbol) price at ther IPO (initial Public Offering) was $21.2500

Q: Is ALKS stock worth buying at the moment?

A: The ALKS stock performance since 2019 are rather disappointing. If you had bought 1 share of Alkermes plc stock (symbol: ALKS) at the beginning of 2019, at the opening share price of $32.8700, you would be left with exactly $21.2500 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Alkermes plc Stock Easy Online

Alkermes plc Stock Ticker Price Chart since IPO:





Alkermes plc Stock Price Yesterday



 


Alkermes plc Stock Price – Last Week




 


Alkermes plc Stock Price – Last Month




 


Alkermes plc Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.zacks.com/stock/news/672970/these-5-loser-stocks-of-2019-could-be-big-winners-in-2020
                            

                                
These 5 Loser Stocks of 2019 Could be Big Winners in 2020

                                
                                
As the momentum in the equity markets is expected to stay on firm-f...


                            

                        
                    

                


                            

                    


                        
                            https://www.forbes.com/sites/greatspeculations/2019/11/26/why-is-alkermes-stock-down-30-so-far-this-year/
                            

                                
Why Is Alkermes Stock Down 30% So Far This Year?

                                
                                
Alkermes (NASDAQ: ALKS) is a biotech company based out of Ireland t...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/629205/alkermes-submits-nda-to-fda-for-schizophrenia-bipolar-i-drug
                            

                                
Alkermes Submits NDA to FDA for Schizophrenia & Bipolar I Drug

                                
                                
Alkermes (ALKS) submits NDA to the FDA seeking approval of ALKS 383...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/627394/alkermes-to-acquire-rodin-therapeutics-boost-cns-pipeline
                            

                                
Alkermes to Acquire Rodin Therapeutics, Boost CNS Pipeline

                                
                                
Alkermes (ALKS) will acquire Rodin Therapeutics for an upfront cash...


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/alkermes-to-acquire-rodin-therapeutics-for-up-to-950-million-2019-11-18
                            

                                
Alkermes to acquire Rodin Therapeutics for up to $950 million

                                
                                
Alkermes Plc said Monday it has agreed to acquire the privately hel...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/commentary/617724/top-ranked-momentum-stocks-to-buy-for-november-13th
                            

                                
Top Ranked Momentum Stocks to Buy for November 13th

                                
                                
Top Ranked Momentum Stocks to Buy for November 13th


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/general/biotech/19/11/14714299/biotech-stock-on-the-radar-alkermes-at-a-crossroads
                            

                                
Biotech Stock On The Radar: Alkermes At A Crossroads

                                
                                
Alkermes Plc (NASDAQ: ALKS), an actively traded, mid-cap biotech, h...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/606147/check-5-best-liquid-stocks-for-impressive-returns
                            

                                
Check 5 Best Liquid Stocks for Impressive Returns

                                
                                
Here are five top-ranked liquid stocks that investors can bank on f...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/678196/5-losing-stocks-from-2019-to-rebound-next-year
                            

                                
5 Losing Stocks From 2019 to Rebound Next Year

                                
                                
The positive sentiment witnessed by Wall Street in 2019 might be pr...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/676478/5-beaten-down-biotech-stocks-set-to-rebound-in-2020
                            

                                
5 Beaten-Down Biotech Stocks Set to Rebound in 2020

                                
                                
Here we discuss some biotech stocks, which are down this year so fa...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/672970/these-5-loser-stocks-of-2019-could-be-big-winners-in-2020
                            

                                
These 5 Loser Stocks of 2019 Could be Big Winners in 2020

                                
                                
As the momentum in the equity markets is expected to stay on firm-f...


                            

                        
                    

                


                            

                    


                        
                            https://www.forbes.com/sites/greatspeculations/2019/11/26/why-is-alkermes-stock-down-30-so-far-this-year/
                            

                                
Why Is Alkermes Stock Down 30% So Far This Year?

                                
                                
Alkermes (NASDAQ: ALKS) is a biotech company based out of Ireland t...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/629205/alkermes-submits-nda-to-fda-for-schizophrenia-bipolar-i-drug
                            

                                
Alkermes Submits NDA to FDA for Schizophrenia & Bipolar I Drug

                                
                                
Alkermes (ALKS) submits NDA to the FDA seeking approval of ALKS 383...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/627394/alkermes-to-acquire-rodin-therapeutics-boost-cns-pipeline
                            

                                
Alkermes to Acquire Rodin Therapeutics, Boost CNS Pipeline

                                
                                
Alkermes (ALKS) will acquire Rodin Therapeutics for an upfront cash...


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/alkermes-to-acquire-rodin-therapeutics-for-up-to-950-million-2019-11-18
                            

                                
Alkermes to acquire Rodin Therapeutics for up to $950 million

                                
                                
Alkermes Plc said Monday it has agreed to acquire the privately hel...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/commentary/617724/top-ranked-momentum-stocks-to-buy-for-november-13th
                            

                                
Top Ranked Momentum Stocks to Buy for November 13th

                                
                                
Top Ranked Momentum Stocks to Buy for November 13th


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.